Get started

Funds · GRCE

Who owns GRCE?

Institutional ownership of Grace Therapeutics Inc. from Form 13F, Q2 2026

33 institutional managers reported holding Grace Therapeutics Inc. (GRCE) in Form 13F filings for Q2 2026, with 3,949,792 shares worth $9.0M. The largest reported holder was Cerity Partners LLC. Managers that filed both quarters cut a net 314,680 shares (-7.4%). 10 opened new positions and 11 sold out.

Funds holding
33
Value held
$9.0M
New / sold out
10 / 11
Net shares, same filers
-7.4%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of GRCE

FundValueShare of 13F holdingsSharesMove
Cerity Partners LLC$1.9M21.5%849,055Unchanged
Eversept Partners, LP$1.8M19.6%772,900Added
Bank of America Corp$1.1M12.5%494,698Unchanged
Vanguard Capital Management LLC$935K10.4%411,714Added
Citadel Advisors LLC$794K8.9%349,740Added
Maven Securities LTD$454K5.1%200,000New
Cantor Fitzgerald, L. P.$454K5.1%200,000New
Birchview Capital, LP$272K3.0%120,000Added
Two Sigma Investments, LP$220K2.5%96,890New
Jane Street Group, LLC$203K2.3%89,442Trimmed
XTX Topco Ltd$163K1.8%71,668Added
HRT Financial LP$142K1.6%62,691New
Susquehanna International Group, LLP$113K1.3%49,577New
BlackRock, Inc.$85K1.0%37,535New
Rangeley Capital, LLC$59K0.7%26,000New
Kestra Private Wealth Services, LLC$52K0.6%23,000Added
UBS Group AG$38K0.4%16,777Trimmed
Stratos Investment Management, LLC$25K0.3%11,158New
BNP Paribas Financial Markets$24K0.3%10,500Added
Scientech Research LLC$23K0.3%10,184New
Virtu Financial LLC$23K0.3%10,166New
Oppenheimer & Co Inc$23K0.3%10,000Unchanged
Morgan Stanley$21K0.2%9,448Added
Vanguard Fiduciary Trust Co$20K0.2%8,750Unchanged
National Bank of Canada$6K0.1%2,680Trimmed

Share of 13F holdings is each fund's shares as a share of the 3,949,792 GRCE shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. Citadel Advisors LLC Added+$570K
  2. Maven Securities LTD New+$454K
  3. Cantor Fitzgerald, L. P. New+$454K
  4. Two Sigma Investments, LP New+$220K
  5. Birchview Capital, LP Added+$159K
  6. HRT Financial LP New+$142K
  7. Susquehanna International Group, LLP New+$113K
  8. BlackRock, Inc. New+$85K
  9. Rangeley Capital, LLC New+$59K
  10. Eversept Partners, LP Added+$37K

Biggest sellers in Q2 2026

  1. Nantahala Capital Management, LLC Sold out-$3.4M
  2. Renaissance Technologies LLC Sold out-$1.1M
  3. Marshall Wace, LLP Sold out-$423K
  4. Connective Capital Management, LLC Sold out-$391K
  5. Quadrature Capital Ltd Sold out-$309K
  6. Diametric Capital, LP Sold out-$184K
  7. Jane Street Group, LLC Trimmed-$176K
  8. Pale Fire Capital SE Sold out-$175K
  9. Prelude Capital Management, LLC Sold out-$47K
  10. Group One Trading LLC Sold out-$23K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $2.5M and sold $6.3M; 12 added and 3 trimmed.

Schedule 13D and 13G filings on GRCE

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about GRCE ownership

Who owns GRCE stock?
33 institutional investment managers reported GRCE positions in their Form 13F filings for Q2 2026, holding 3,949,792 shares worth $9.0M in total. Cerity Partners LLC reported the largest position.
Are funds buying or selling GRCE?
In Q2 2026, 10 managers opened new GRCE positions, 12 added, 3 trimmed and 11 sold out. Managers that filed in both quarters sold a net 314,680 shares.
How current is this GRCE institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to GRCE by CUSIP. Options are left out. GRCE news and filings · GRCE insider trades · Top funds